• Home
  • About CML
    • Who We Are
    • What we Do
    • Mission & Vision
    • The Patient Advisory Board
  • What is CML
  • Treatments
    • Access
    • Living Well
    • Clinical Trials
  • News
  • Contact
  • Home
  • About CML
    • Who We Are
    • What we Do
    • Mission & Vision
    • The Patient Advisory Board
  • What is CML
  • Treatments
    • Access
    • Living Well
    • Clinical Trials
  • News
  • Contact

Monitoring the disease

•22 October 2024

Medical Tests

Blood tests

Bone Marrow Aspirate – Bone Marrow Biopsy

Flourescent in-situ-hybridization test (FISH)

Polymerase Chain Reaction

Previous PostBlood testNext PostClinical Trials

Related Posts

ACCESS TO AFFORDABLE MEDICINE FOR ALL

CML Access to Medicine

APO-IMATINIB

Apo – imatinib – Treatment for CML

Recent Articles

ACCESS TO AFFORDABLE MEDICINE FOR ALL
CML Access to Medicine
22 October 2024Chronic Myelogenous Leukemia Society of Canada
APO-IMATINIB
Apo – imatinib – Treatment for CML
22 October 2024Chronic Myelogenous Leukemia Society of Canada
ASH 2013
ASH 2013 – Newsletter
22 October 2024Chronic Myelogenous Leukemia Society of Canada

Text Widget

Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada.

Our Services



CML Society of Canada provides support, education and information on CML, current and emerging treatments and research initiatives for people living with CML and their families.

Contact Centre

1 (514) 239-5488

All Across Canada

Mon – Fri: 8.00am 6.00pm

Member Resources

  • About CML
  • What is CML
  • Contact Us
  • Treatments
  • News
  • Videos

Our Newsletter

Copyright ©2024 CML. All Rights Reserved. Legal and Privacy.